Fillers: from the past to the future.
Modern medical use of injectable soft-tissue augmentation fillers has evolved from the introduction of bovine collage implants to an array of synthesized materials in the current domestic and foreign markets. The concept of augmentation has moved from simple lines, scars, and wrinkles to revolumizing the aging face. A brief overview of the past, present, and future injectable fillers is presented.
Department of Dermatology, University of California, San Francisco, CA 94117-3685, USA. rglogau@aol.com
Richard G
RG
Glogau
D000273:Adipose Tissue / Q000637:transplantation; D000375:Aging; D000818:Animals; D001672:Biocompatible Materials / Q000008:administration & dosage*; D002482:Cellulose / Q000008:administration & dosage; D003094:Collagen / Q000008:administration & dosage; D017886:Durapatite / Q000008:administration & dosage; D005544:Forecasting; D006801:Humans; D006820:Hyaluronic Acid / Q000031:analogs & derivatives; D019344:Lactic Acid / Q000008:administration & dosage; D008353:Mannitol / Q000008:administration & dosage; D019904:Polymethyl Methacrylate / Q000008:administration & dosage; D012060:Rejuvenation; D012828:Silicones / Q000008:administration & dosage; D015595:Skin Aging
C516180:ArteFill; D001672:Biocompatible Materials; C482305:New-Fill; D012828:Silicones; D019344:Lactic Acid; D008353:Mannitol; D002482:Cellulose; D006820:Hyaluronic Acid; D003094:Collagen; D019904:Polymethyl Methacrylate; D017886:Durapatite